Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ponalrestat does not cause a protein binding interaction with warfarin in diabetic patients.

Autor: Moulds, RF, Fullinfaw, RO, Bury, RW, Plehwe, WE, Jacka, N., McGrath, KM, Martin, FI

Publikováno v: British Journal of Clinical Pharmacology; 1991, Vol. 31 Issue 6, p715-718, 4p

Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?

Autor: Flavell AL; Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia. adam.flavell@wh.org.au., Fullinfaw RO; Department of Chemical Pathology, The Royal Melbourne Hospital, Parkville, Australia., Smith ER; Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Australia., Holt SG; Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Australia., Finlay MJ; Department of Medicine, The University of Melbourne, Melbourne, Australia.; Department of Anatomical Pathology, The Royal Melbourne Hospital, Parkville, Australia., Barbour TD; Department of Nephrology, The Royal Melbourne Hospital, Parkville, Australia.; Department of Medicine, The University of Melbourne, Melbourne, Australia.

Publikováno v: BMC nephrology [BMC Nephrol] 2020 Jul 23; Vol. 21 (1), pp. 293. Date of Electronic Publication: 2020 Jul 23.

An international multi-center serum protein electrophoresis accuracy and M-protein isotyping study. Part II: limit of detection and follow-up of patients with small M-proteins.

Autor: Jacobs JFM; Laboratory Medical Immunology, Department of Laboratory Medicine, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands., Turner KA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Graziani MS; Section of Clinical Biochemistry, University of Verona, Verona, Italy., Frinack JL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Ettore MW; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Tate JR; Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Booth RA; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada., McCudden CR; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada., Keren DF; Department of Pathology, The University of Michigan, Ann Arbor, MI, USA., Delgado JC; ARUP Laboratories, Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA., Zemtsovskaja G; Clinical Chemistry Laboratory, North Estonia Medical Centre, Tallinn, Estonia., Fullinfaw RO; Department of Chemical Pathology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Caldini A; General Laboratory, Careggi University Hospital, Florence, Italy., de Malmanche T; NSW Health Pathology, Immunology Department, John Hunter Hospital, New Lambton Heights NSW, Australia., Katakouzinos K; Immunopathology Department, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Burke M; Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia., Palladini G; Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Altinier S; Laboratory Medicine of the University Hospital of Padova, Padova, Italy., Zaninotto M; Laboratory Medicine of the University Hospital of Padova, Padova, Italy., Righetti G; Clinical Chemistry Laboratory, University of Verona, Verona, Italy., Melki MT; Sebia Inc., Lisses, France., Bell S; Helena Biosciences Europe, Sunderland, UK., Willrich MAV; Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2020 Mar 26; Vol. 58 (4), pp. 547-559.

Open-Label Study of Absorption and Clearance of 1% Voriconazole Eye Drops.

Autor: Neoh CF; Collaborative Drug Discovery Research (CDDR) Group, Faculty of Pharmacy, Universiti Teknologi MARA, Puncak Alam, Selangor, Malaysia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Leung L; Department of Pharmacy, Royal Victorian Eye and Ear Hospital (RVEEH), East Melbourne, Victoria, Australia., Chan E; Corneal Unit, Royal Victorian Eye and Ear Hospital (RVEEH), Centre for Eye Research Australia, East Melbourne, Victoria, Australia., Al-Badriyeh D; College of Pharmacy, Qatar University, Doha, Qatar., Fullinfaw RO; Special Chemistry, Melbourne Health Pathology, The Royal Melbourne Hospital, Parkville, Victoria, Australia., Jhanji V; Corneal Unit, Royal Victorian Eye and Ear Hospital (RVEEH), Centre for Eye Research Australia, East Melbourne, Victoria, Australia.; Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, China., Vajpayee RB; Corneal Unit, Royal Victorian Eye and Ear Hospital (RVEEH), Centre for Eye Research Australia, East Melbourne, Victoria, Australia., Davies GE; Department of Pharmacy, Royal Victorian Eye and Ear Hospital (RVEEH), East Melbourne, Victoria, Australia.; Health Systems Program Office, Integrated Soldier Systems Branch, Land Systems Division, Capability Acquisition and Sustainment Group, Department of Defence, Victoria Barracks Melbourne, Southbank, Victoria, Australia., Stewart K; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Kong DC; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia david.kong@monash.edu.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2016 Oct 21; Vol. 60 (11), pp. 6896-6898. Date of Electronic Publication: 2016 Oct 21 (Print Publication: 2016).